Boston Scientific (BSX) Assets Average (2009 - 2026)

Boston Scientific's Assets Average history runs 18 years deep, the most recent figure standing at $44.0 billion for Q1 2026.

• In Q1 2026, Assets Average rose 10.67% year-over-year to $44.0 billion; the TTM figure through Mar 2026 stood at $44.0 billion (up 10.67% YoY), while the FY2025 annual figure was $41.5 billion, up 11.45% from the prior year.
• Assets Average came in at $44.0 billion for Q1 2026 at Boston Scientific, up from $43.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $44.0 billion in Q1 2026 to a low of $32.1 billion in Q3 2022.
• A 5-year average of $36.6 billion and a median of $35.9 billion in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average increased 0.48% in 2022 and gained 12.08% in 2025, its largest moves.
• Boston Scientific's Assets Average stood at $32.2 billion in 2022, then gained by 7.39% to $34.6 billion in 2023, then advanced by 11.99% to $38.7 billion in 2024, then grew by 11.5% to $43.2 billion in 2025, then advanced by 1.9% to $44.0 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $44.0 billion, $43.2 billion, and $42.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison